Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-186271
Filing Date
2024-07-26
Accepted
2024-07-26 16:33:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d868345d424b5.htm 424B5 344106
2 GRAPHIC g868345g00g03.jpg GRAPHIC 62704
  Complete submission text file 0001193125-24-186271.txt   431759
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

EIN.: 134196017 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265470 | Film No.: 241147539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)